{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:00:49Z","timestamp":1790362849132,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10096-021-04262-x","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T18:02:35Z","timestamp":1620151355000},"page":"2137-2144","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Revisiting the inoculum effect for Streptococcus pyogenes with a hollow fibre infection model"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6695-1288","authenticated-orcid":false,"given":"Darcy","family":"Marum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurens","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Raby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"key":"4262_CR1","unstructured":"E. A, L. T. (2016) Streptococcus pyogenes: basic biology to clinical manifestations Oklahoma City: University of Oklahoma Health Sciences Center."},{"key":"4262_CR2","doi-asserted-by":"crossref","unstructured":"Wright CM, Langworthy K, Manning L. (2020) The Australian burden of invasive group A streptococcal disease\u2014a narrative review. Intern Med J; n\/a.","DOI":"10.1111\/imj.14885"},{"key":"4262_CR3","unstructured":"Zimbelman J, Palmer A Fau-Todd J, Todd J. (n.d.) Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection."},{"key":"4262_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/clinids\/11.3.361","volume":"11","author":"I Brook","year":"1989","unstructured":"Brook I (1989) Inoculum effect. Rev Infect Dis 11:361\u2013368","journal-title":"Rev Infect Dis"},{"key":"4262_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0002-9343(52)90293-3","volume":"13","author":"H Eagle","year":"1952","unstructured":"Eagle H (1952) Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice. Am J Med 13:389\u2013399","journal-title":"Am J Med"},{"key":"4262_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/158.1.23","volume":"158","author":"DL Stevens","year":"1988","unstructured":"Stevens DL, Gibbons AE, Bergstrom R et al (1988) The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 158:23\u201328","journal-title":"J Infect Dis"},{"key":"4262_CR7","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/infdis\/167.6.1401","volume":"167","author":"DL Stevens","year":"1993","unstructured":"Stevens DL, Yan S, Bryant AE (1993) Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. J Infect Dis 167:1401\u20131405","journal-title":"J Infect Dis"},{"key":"4262_CR8","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/cid\/civ462","volume":"61","author":"KA Wargo","year":"2015","unstructured":"Wargo KA, McCreary EK, English TM (2015) Vancomycin combined With Clindamycin for the treatment of acute bacterial skin and skin-structure infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 61:1148\u20131154","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"4262_CR9","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/cid\/civ465","volume":"61","author":"CM Bland","year":"2015","unstructured":"Bland CM, Bookstaver PB (2015) Editorial Commentary: Double Gram-positive coverage for acute bacterial skin and skin structure infections: has the Eagle landed? Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 61:1155\u20131156","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"key":"4262_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.mib.2013.06.010","volume":"16","author":"T Velkov","year":"2013","unstructured":"Velkov T, Bergen PJ, Lora-Tamayo J et al (2013) PK\/PD models in antibacterial development. Curr Opin Microbiol 16:573\u2013579","journal-title":"Curr Opin Microbiol"},{"key":"4262_CR11","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7883\/yoken.63.304","volume":"63","author":"T Ikebe","year":"2010","unstructured":"Ikebe T, Wada A, Oguro Y et al (2010) Emergence of clindamycin-resistant Streptococcus pyogenes isolates obtained from patients with severe invasive infections in Japan. Jpn J Infect Dis 63:304\u2013305","journal-title":"Jpn J Infect Dis"},{"key":"4262_CR12","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.jgar.2020.04.032","volume":"22","author":"AE Bryant","year":"2020","unstructured":"Bryant AE, Bayer CR, Aldape MJ et al (2020) Emerging erythromycin and clindamycin resistance in group A streptococci: efficacy of linezolid and tedizolid in experimental necrotizing infection. J Glob Antimicrob Resist 22:601\u2013607","journal-title":"J Glob Antimicrob Resist"},{"key":"4262_CR13","doi-asserted-by":"publisher","first-page":"ofx232","DOI":"10.1093\/ofid\/ofx232","volume":"4","author":"AC Bowen","year":"2017","unstructured":"Bowen AC, Carapetis JR, Currie BJ et al (2017) Sulfamethoxazole-Trimethoprim (Cotrimoxazole) for skin and soft tissue infections including impetigo, cellulitis, and abscess. Open Forum Infect Dis 4:ofx232","journal-title":"Open Forum Infect Dis"},{"key":"4262_CR14","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1128\/JCM.02195-12","volume":"50","author":"AC Bowen","year":"2012","unstructured":"Bowen AC, Lilliebridge RA, Tong SYC et al (2012) Is Streptococcus pyogenes resistant or susceptible to Trimethoprim-Sulfamethoxazole? J Clin Microbiol 50:4067\u20134072","journal-title":"J Clin Microbiol"},{"key":"4262_CR15","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3201\/eid1410.071660","volume":"14","author":"RK Aziz","year":"2008","unstructured":"Aziz RK, Kotb M (2008) Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis 14:1511\u20131517","journal-title":"Emerg Infect Dis"},{"key":"4262_CR16","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1046\/j.1469-0691.2003.00790.x","volume":"9","author":"Microbiology ECfASTotESoC","year":"2003","unstructured":"Microbiology ECfASTotESoC (2003) Diseases I. Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin Microbiol Infect 9:ix\u2013xv","journal-title":"Clin Microbiol Infect"},{"key":"4262_CR17","unstructured":"Breakpoint tables for interpretation of MICs and zone diameters. In: Testing TECoAS, ed, (2018)."},{"key":"4262_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/clinids\/17.3.491","volume":"17","author":"LG Visser","year":"1993","unstructured":"Visser LG, Arnouts P, van Furth R et al (1993) Clinical pharmacokinetics of continuous intravenous administration of penicillins. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 17:491\u2013495","journal-title":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"},{"key":"4262_CR19","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1128\/AAC.01046-07","volume":"52","author":"KL LaPlante","year":"2008","unstructured":"LaPlante KL, Leonard SN, Andes DR et al (2008) Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models. Antimicrob Agents Chemother 52:2156\u20132162","journal-title":"Antimicrob Agents Chemother"},{"key":"4262_CR20","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1093\/jac\/dkz226","volume":"74","author":"JR Lenhard","year":"2019","unstructured":"Lenhard JR, Bulman ZP (2019) Inoculum effect of beta-lactam antibiotics. J Antimicrob Chemother 74:2825\u20132843","journal-title":"J Antimicrob Chemother"},{"key":"4262_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/jac\/dkf058","volume":"50","author":"RC Mercier","year":"2002","unstructured":"Mercier RC, Stumpo C, Rybak MJ (2002) Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faecium. J Antimicrob Chemother 50:19\u201324","journal-title":"J Antimicrob Chemother"},{"key":"4262_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1046\/j.1365-2958.2001.02616.x","volume":"42","author":"WR Lyon","year":"2001","unstructured":"Lyon WR, Madden JC, Levin JC et al (2001) Mutation of luxS affects growth and virulence factor expression in Streptococcus pyogenes. Mol Microbiol 42:145\u2013157","journal-title":"Mol Microbiol"},{"key":"4262_CR23","doi-asserted-by":"publisher","first-page":"5633","DOI":"10.1128\/IAI.71.10.5633-5639.2003","volume":"71","author":"MJ Marouni","year":"2003","unstructured":"Marouni MJ, Sela S (2003) The luxS gene of Streptococcus pyogenes regulates expression of genes that affect internalization by epithelial cells. Infect Immun 71:5633\u20135639","journal-title":"Infect Immun"},{"key":"4262_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1093\/jac\/dkl560","volume":"59","author":"PD Rogers","year":"2007","unstructured":"Rogers PD, Liu TT, Barker KS et al (2007) Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. J Antimicrob Chemother 59:616\u2013626","journal-title":"J Antimicrob Chemother"},{"key":"4262_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ijantimicag.2012.08.016","volume":"41","author":"T Xue","year":"2013","unstructured":"Xue T, Zhao L, Sun B (2013) LuxS\/AI-2 system is involved in antibiotic susceptibility and autolysis in Staphylococcus aureus NCTC 8325. Int J Antimicrob Ag 41:85\u201389","journal-title":"Int J Antimicrob Ag"},{"key":"4262_CR26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1469-0691.2009.02893.x","volume":"16","author":"L L\u00f3pez-Cerero","year":"2010","unstructured":"L\u00f3pez-Cerero L, Pic\u00f3n E, Morillo C et al (2010) Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum \u03b2-lactamase-producing and extended-spectrum \u03b2-lactamase-non-producing Escherichia coli isolates. Clin Microbiol Infect 16:132\u2013136","journal-title":"Clin Microbiol Infect"},{"key":"4262_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.diagmicrobio.2003.11.007","volume":"49","author":"DS Burgess","year":"2004","unstructured":"Burgess DS, Hall RG (2004) In vitro killing of parenteral beta-lactams against standard and high inocula of extended-spectrum beta-lactamase and non-esbl producing klebsiella pneumoniae. Diagn Microbiol Infect Dis 49:41\u201346","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4262_CR28","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1128\/AAC.00539-06","volume":"51","author":"J Sawai","year":"2007","unstructured":"Sawai J, Hasegawa T, Kamimura T et al (2007) Growth phase-dependent effect of clindamycin on production of exoproteins by Streptococcus pyogenes. Antimicrob Agents Chemother 51:461\u2013467","journal-title":"Antimicrob Agents Chemother"},{"key":"4262_CR29","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1128\/AAC.00362-12","volume":"57","author":"D-G Lee","year":"2013","unstructured":"Lee D-G, Murakami Y, Andes DR et al (2013) Inoculum Effects of Ceftobiprole, Daptomycin, Linezolid, and Vancomycin with Staphylococcus aureus and Streptococcus pneumoniae at inocula of 105and 107CFU injected into opposite thighs of neutropenic mice. Antimicrob Agents Chemother 57:1434\u20131441","journal-title":"Antimicrob Agents Chemother"},{"key":"4262_CR30","first-page":"59","volume":"112","author":"WD Leers","year":"1975","unstructured":"Leers WD (1975) In vitro sensitivity of hemophilus influenzae and streptococcus pyogenes to co-trimoxazole. Can Med Assoc J 112:59\u201363","journal-title":"Can Med Assoc J"},{"key":"4262_CR31","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/0006-2952(77)90271-4","volume":"26","author":"H Nottebrock","year":"1977","unstructured":"Nottebrock H, Then R (1977) Thymidine concentrations in serum and urine of different animal species and man. Biochem Pharmacol 26:2175\u20132179","journal-title":"Biochem Pharmacol"},{"key":"4262_CR32","doi-asserted-by":"publisher","first-page":"ofy123","DOI":"10.1093\/ofid\/ofy123","volume":"5","author":"WR Miller","year":"2018","unstructured":"Miller WR, Seas C, Carvajal LP et al (2018) The Cefazolin inoculum effect is associated with increased mortality in methicillin-susceptible Staphylococcus aureus bacteremia. Open forum infectious diseases 5:ofy123\u2013ofyofy","journal-title":"Open forum infectious diseases"},{"key":"4262_CR33","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/mdr.2013.0229","volume":"20","author":"S Lee","year":"2014","unstructured":"Lee S, Kwon KT, Kim H-I et al (2014) Clinical implications of Cefazolin inoculum effect and \u03b2-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia. Microb Drug Resist 20:568\u2013574","journal-title":"Microb Drug Resist"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-021-04262-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-021-04262-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T05:17:45Z","timestamp":1672031865000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-021-04262-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["4262"],"URL":"https:\/\/doi.org\/10.1007\/s10096-021-04262-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.01.07.425826","asserted-by":"object"}]},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"20 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None to declare","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}}]}}